跳至主要内容
临床试验/CTRI/2021/08/036095
CTRI/2021/08/036095尚未招募2 期

A Prospective, Randomized, Parallel Group, Open Label, Active ControlledClinical Study to Evaluate the Efficacy and Safety of a Polyherbal UnaniFormulation in the Management of Buthūr Labaniyya (Acne Vulgaris)

ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of any sex in the age group between 14 and 40 Years
  • 2. Clinically stable patients
  • 3. Patients having the following symptoms of ButhÅ«r Labaniyya:
  • Comedones, Papules, Pustules, Nodules, Itching, Erythema.

排除标准

  • 1. Patients aged 40 years
  • 2. Pregnant or Lactating Women
  • 3. Mentally retarded person
  • 4. Patients on corticosteroid or anticonvulsant therapy or taking oral
  • contraceptives
  • 5. Patients suffering from other concomitant diseases like acne
  • rosacea, acne fulminance, acne necrotica, psoriasis, eczema, etc.
  • 6. Significant Pulmonary/Cardiovascular/Hepato-renal dysfunction
  • 7. Patient not willing to attend treatment schedule regularly

研究者

发起方
ational Research Institute of Unani Medicine for Skin Disorders

相似试验